Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA.

Tobias B Haack | Penelope Hogarth | Michael C Kruer | Allison Gregory | Thomas Wieland | Thomas Schwarzmayr | Elisabeth Graf | Lynn Sanford | Esther Meyer | Eleanna Kara | Stephan M Cuno | Sami I Harik | Vasuki H Dandu | Nardo Nardocci | Giovanna Zorzi | Todd Dunaway | Mark Tarnopolsky | Steven Skinner | Steven Frucht | Era Hanspal | Connie Schrander-Stumpel | Delphine Héron | Cyril Mignot | Barbara Garavaglia | Kailash Bhatia | John Hardy | Tim M Strom | Nathalie Boddaert | Henry H Houlden | Manju A Kurian | Thomas Meitinger | Holger Prokisch | Susan J Hayflick
American journal of human genetics | 2012

Neurodegeneration with brain iron accumulation (NBIA) is a group of genetic disorders characterized by abnormal iron deposition in the basal ganglia. We report that de novo mutations in WDR45, a gene located at Xp11.23 and encoding a beta-propeller scaffold protein with a putative role in autophagy, cause a distinctive NBIA phenotype. The clinical features include early-onset global developmental delay and further neurological deterioration (parkinsonism, dystonia, and dementia developing by early adulthood). Brain MRI revealed evidence of iron deposition in the substantia nigra and globus pallidus. Males and females are phenotypically similar, an observation that might be explained by somatic mosaicism in surviving males and germline or somatic mutations in females, as well as skewing of X chromosome inactivation. This clinically recognizable disorder is among the more common forms of NBIA, and we suggest that it be named accordingly as beta-propeller protein-associated neurodegeneration.

Pubmed ID: 23176820

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: Medical Research Council, United Kingdom
    Id: G108/638
  • Agency: Telethon, Italy
    Id: GTB07001
  • Agency: NCRR NIH HHS, United States
    Id: UL1 RR024140
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000128
  • Agency: Medical Research Council, United Kingdom
    Id: G0802760
  • Agency: Medical Research Council, United Kingdom
    Id: G1001253

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


OMIM (tool)

RRID:SCR_006437

Online catalog of human genes and genetic disorders, for clinical features, phenotypes and genes. Collection of human genes and genetic phenotypes, focusing on relationship between phenotype and genotype. Referenced overviews in OMIM contain information on all known mendelian disorders and variety of related genes. It is updated daily, and entries contain copious links to other genetics resources.

View all literature mentions

MutationTaster (tool)

RRID:SCR_010777

Evaluates disease-causing potential of sequence alterations.

View all literature mentions

NHLBI Exome Sequencing Project (ESP) (tool)

RRID:SCR_012761

The goal of the project is to discover novel genes and mechanisms contributing to heart, lung and blood disorders by pioneering the application of next-generation sequencing of the protein coding regions of the human genome across diverse, richly-phenotyped populations and to share these datasets and findings with the scientific community to extend and enrich the diagnosis, management and treatment of heart, lung and blood disorders. The groups participating and collaborating in the NHLBI GO ESP include: Seattle GO - University of Washington, Seattle, WA Broad GO - Broad Institute of MIT and Harvard, Cambridge, MA WHISP GO - Ohio State University Medical Center, Columbus, OH Lung GO - University of Washington, Seattle, WA WashU GO - Washington University, St. Louis, MO Heart GO - University of Virginia Health System, Charlottesville, VA ChargeS GO - University of Texas Health Sciences Center at Houston

View all literature mentions

PolyPhen: Polymorphism Phenotyping (tool)

RRID:SCR_013189

Software tool which predicts possible impact of amino acid substitution on structure and function of human protein using straightforward physical and comparative considerations. PolyPhen-2 is new development of PolyPhen tool for annotating coding nonsynonymous SNPs.

View all literature mentions

GENSCAN (tool)

RRID:SCR_013362

Web server for identification of complete gene structures in genomic DNA.Tool for predicting locations and exon-intron structures of genes in genomic sequences from variety of organisms. Used for prediction of complete gene structures in human genomic DNA.

View all literature mentions